Cargando…

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021

Detalles Bibliográficos
Autores principales:	Nanduri, Srinivas, Pilishvili, Tamara, Derado, Gordana, Soe, Minn Minn, Dollard, Philip, Wu, Hsiu, Li, Qunna, Bagchi, Suparna, Dubendris, Heather, Link-Gelles, Ruth, Jernigan, John A., Budnitz, Daniel, Bell, Jeneita, Benin, Andrea, Shang, Nong, Edwards, Jonathan R., Verani, Jennifer R., Schrag, Stephanie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389386/ https://www.ncbi.nlm.nih.gov/pubmed/34437519 http://dx.doi.org/10.15585/mmwr.mm7034e3

Ejemplares similares

Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
por: Prasad, Namrata, et al.
Publicado: (2022)

Serial intervals in SARS-CoV-2 B.1.617.2 variant cases
por: Pung, Rachael, et al.
Publicado: (2021)

Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents — United States, November 20, 2022–January 8, 2023
por: Wong, Emily, et al.
Publicado: (2023)

Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status — United States, October 10, 2022–January 8, 2023
por: Dubendris, Heather, et al.
Publicado: (2023)

SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves — United States, June 30, 2021–September 27, 2022
por: Navarrete, Jose, et al.
Publicado: (2023)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
por: Mlcochova, Petra, et al.
Publicado: (2021)

Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2
por: Li, Gun, et al.
Publicado: (2022)

Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Chun, June Young, et al.
Publicado: (2022)

Charge transport properties of SARS-CoV-2 Delta variant (B.1.617.2)
por: He, Lijun, et al.
Publicado: (2022)

Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets
por: Sun, Xiangjie, et al.
Publicado: (2023)

Ecological Analysis of the Decline in Incidence Rates of COVID-19 Among Nursing Home Residents Associated with Vaccination, United States, December 2020-January 2021
por: Benin, Andrea L., et al.
Publicado: (2021)

Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant
por: Rosato, Adriana E., et al.
Publicado: (2022)

B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies
por: Zhan, Yan, et al.
Publicado: (2022)

Genome Sequences of 15 SARS-CoV-2 Sublineage B.1.617.2 Strains in Bangladesh
por: Afrad, Mokibul Hassan, et al.
Publicado: (2021)

SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
por: Lowry, Kym, et al.
Publicado: (2022)

Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom
por: Emani, Venkata R., et al.
Publicado: (2022)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Sakai-Tagawa, Yuko, et al.
Publicado: (2021)

SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise
por: Shook, Lydia L, et al.
Publicado: (2022)

Genome Sequencing of the SARS-CoV-2 Delta (B.1.617.2) Variant of Concern Detected in Bangladesh
por: Banu, Tanjina Akhtar, et al.
Publicado: (2021)

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
por: Davis, Chris, et al.
Publicado: (2021)

Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus
por: Mak, Gannon CK, et al.
Publicado: (2022)

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
por: Dhawan, Manish, et al.
Publicado: (2022)

Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant
por: Jeican, Ionuț Isaia, et al.
Publicado: (2023)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)

Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020–July 2021
por: Geller, Andrew I., et al.
Publicado: (2022)

SARS-CoV-2 and Tacrolimus Blood Concentration in Kidney Transplant Recipients
por: McMinn, Jason, et al.
Publicado: (2021)

Epidemiological analysis of SARS-COV-2 B.1.617.2 (delta variant) transmission in an educational institute
por: Vishnu Prasad, S., et al.
Publicado: (2022)

SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Taytard, Jessica, et al.
Publicado: (2022)

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Wang, Fuzhen, et al.
Publicado: (2021)

Genome Sequences of SARS-CoV-2 Sublineage B.1.617.2 Strains from 12 Children in Chattogram, Bangladesh
por: Mannan, Adnan, et al.
Publicado: (2021)

Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients
por: Wand, Ori, et al.
Publicado: (2022)

First Detection of SARS-CoV-2 B.1.617.2 (Delta) Variant of Concern in a Symptomatic Cat in Spain
por: Barroso-Arévalo, Sandra, et al.
Publicado: (2022)

Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil
por: Lamarca, Alessandra P., et al.
Publicado: (2022)

Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats
por: Hoyte, Ashley, et al.
Publicado: (2022)

Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
por: Caserta, Leonardo C., et al.
Publicado: (2022)

Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistance
por: KS, Sandhya, et al.
Publicado: (2023)

COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2
por: Kumar, Nitya, et al.
Publicado: (2022)

Inhibition of SARS-CoV-2 wild-type (Wuhan-Hu-1) and Delta (B.1.617.2) strains by marine sulfated glycans
por: Dwivedi, Rohini, et al.
Publicado: (2022)

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
por: Link-Gelles, Ruth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_80t14hj5b8opjh4oorbqe6kqck